December 5, 2018
Palo Alto, CA
This workshop addresses the ability to appeal an adverse decision from U.S. Patent and Trademark Office (USPTO) proceedings, the latest significant decisions from the Patent Trial and Appeal Board (PTAB), venue selection for litigation, and the impact of “blocking patents” on objective indicia of non-obviousness. Life sciences patent practitioners have a multitude of factors to consider in protecting their own portfolios and evaluating the portfolios of others. Please join us as we address these issues and provide insight to help guide your practice, including:
Speakers:
Paul Barker
Barbara Rudolph
Jeffrey Smyth
Linda Wadler
Date:
Wednesday, December 5, 2018
Time:
12:30 - 1:00 p.m.
Registration and Lunch
1:00 - 5:00 p.m.
Workshop
5:00 - 6:00 p.m.
Reception
Location:
Palo Alto, CA
Who Should Attend: In-house patent professionals and anyone with responsibility for/interest in protecting or investing in a company’s intellectual property.
RSVP: If you are an in-house patent professional and would like to arrange an invitation, please contact us by Monday, December 3, 2018. There is no charge to attend.
MCLE Credit: Finnegan confirms that this activity has been certified for 3.75 hours of California MCLE.
Conference
2nd Annual Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities
March 20, 2024
Boston
Ad Law Buzz Blog
“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides
March 18, 2024
At the PTAB Blog
Federal Circuit PTAB Appeal Statistics for December 2023 and January 2024
March 8, 2024
Articles
How to Avoid Common Pitfalls and Protect IP in Today’s Life Sciences Industry Joint Ventures
February 29, 2024
Webinar
February 15, 2024
Webinar
At the PTAB Blog
February 15, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.